[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BussinBiotech Avatar @BussinBiotech Bussin Biotech

Bussin Biotech posts on X about drugs, $agio, $bmy, $2786m the most. They currently have XXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks

Social topic influence drugs, $agio, $bmy, $2786m, h1, $13148m, $7262m, $muel

Top assets mentioned Agios Pharmaceuticals, Inc. (AGIO) Bristol-Myers Squibb Co (BMY)

Top Social Posts #

Top posts by engagements in the last XX hours

"$AGIO $BMY Great article published comparing Lusptercept vs mitapivat for non-transfusion-dependent beta-thalassemia. Article was authored by highly respected hematologists who served as investigators on both of the drugs pivotal trials summary below 🧵"
@BussinBiotech Avatar @BussinBiotech on X 2025-07-15 22:07:43 UTC XXX followers, XXX engagements

"$MUEL Q2 Earnings Came Out Last Week Friday My Personal Highlights Below: Record-breaking performance continues in Q2. Net sales of $72.62M for Q2 (up XXXX% YoY) and $131.48M for H1 2025 (up XXXX% YoY) growth led by strong demand for U.S. industrial equipment and pharmaceutical sectors. Gross profit of $27.86M (up XXXX% YoY) Diluted EPS of $XXXXX (up XX% YoY) a record quarter for shareholder earnings. Backlog at $234.2M (up XX% YoY) driven by $42.4M increase in U.S. backlog especially within pharmaceutical-focused industrial equipment. Operating cash flow of $25.8M YTD (up XXX% YoY)"
@BussinBiotech Avatar @BussinBiotech on X 2025-07-28 14:36:37 UTC XXX followers, 2262 engagements